Twist Bioscience Crashes Despite Quarterly Beat, Solid Guidance

Detailed summary

Twist Bioscience stock took a header Thursday after the company reported better-than-expected fiscal fourth-quarter metrics. The post Twist Bioscience Crashes Despite Quarterly…

Twist Bioscience (TWST) stock tumbled early Thursday after the biotech company reported a loss of 32 cents per share on $126.6 million in fiscal fourth-quarter sales. On average, analysts surveyed by FactSet expected Twist to lose 39 cents a share and report $123.5 million in sales. During the year-earlier period, Twist Bioscience lost 45 cents per share and generated $99…

Opening of the article, excerpted from Investor's Business Daily. To read the rest, open the article on the publisher's site.